"Adventist Health is a faith-based, nonprofit integrated health system serving more than 80 communities on the West Coast and Hawaii. Our compassionate and talented team of 37,000 includes associates, medical staff physicians, allied health professionals and volunteers driven in pursuit of one mission: living God's love by inspiring health, wholeness and hope. Together, we are transforming the American healthcare experience with an innovative, yet timeless, whole-person focus on physical, mental, spiritual and social healing."

During the past decade, Fremont - Rideout Cancer Center conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 47 clinical trials were completed, i.e. on average, 66.2% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 25 clinical trials were completed. i.e. 96.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fremont - Rideout Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NRG Oncology" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fremont - Rideout Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Fremont - Rideout Cancer Center" are "Recurrent Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Prostate Adenocarcinoma" (5 trials) and "Recurrent Squamous Cell Lung Carcinoma" (5 trials). Many other conditions were trialed in "Fremont - Rideout Cancer Center" in a lesser frequency.

Most popular intervention types in "Fremont - Rideout Cancer Center" are "Drug" (93 trials), "Other" (67 trials), "Biological" (47 trials), "Procedure" (27 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (26 trials), "Biospecimen Collection" (17 trials), "Questionnaire Administration" (16 trials) and "Computed Tomography" (15 trials). Other intervention names were less common.

The vast majority of trials in "Fremont - Rideout Cancer Center" are 92 trials for "All" genders, 9 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Fremont - Rideout Cancer Center". undefined are not yet recruiting, 26 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Fremont - Rideout Cancer Center, 3 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Fremont - Rideout Cancer Center, 2 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".